CLINICAL SYMPTOMS AND BIOCHEMICAL-PROPERTIES OF 3 NEW GLUCOSEPHOSPHATE ISOMERASE VARIANTS
CLINICAL SYMPTOMS AND BIOCHEMICAL-PROPERTIES OF 3 NEW GLUCOSEPHOSPHATE ISOMERASE VARIANTS
复制标题
DOI:
10.1007/bf00320579
复制
发表时间:
1986-07-01
期刊:
影响因子:
--
通讯作者:
SCHROTER, W
中科院分区:
文献类型:
--
作者:
EBER, SW;GAHR, M;SCHROTER, W
Glucosephosphate isomerase deficiency as the cause of macrocytic congenital nonspherocytic hemolytic anemia is described in three unrelated families. The biochemical properties of the variant glucosephosphate isomerases indicate that the patients have new variants, designated as GPI Kiel, GPI Hamburg, and GPI Homburg. The severity of the clinical symptoms depended on the amount of residual GPI activity and the biochemical properties of the variant enzyme. Thus, the patient with GPI Kiel (34% residual activity) whose variant GPI was slightly unstable showed a mild chronic hemolytic anemia. The patient with GPI Homburg (7% residual activity) whose variant enzyme was stable and had a reduced specific activity, suffered from severe congenital hemolytic anemia and neuromuscular symptoms. Due to the special properties of GPI Homburg, we assume that both the hematological and neuromuscular symptoms of the patient with GPI Homburg are caused by his GPI deficiency. The twins with GPI Hamburg (27% residual activity) had a distinctly unstable variant enzyme and had suffered from hemolytic crises since birth. Only GPI Homburg showed an altered electrophoretic mobility and an increased affinity for fructose-6-phosphate. The other two variants had normal values.